Overview Fundamentals API Earnings EOD API Sample Code Pricing

Evaxion Biotech AS (EVAX NASDAQ) stock market data APIs

$3.12 -0.18(-5.5%) as of July 12, 2024
Price chart is built with Anychart

Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase 1/2a trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy that is in pre-clinical stage for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. Evaxion Biotech A/S was incorporated in 2008 and is based in Horsholm, Denmark.

Evaxion Biotech AS Financial Data Overview

17 856 K
5 411 K
124 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'EVAX',
Type: 'Common Stock',
Name: 'Evaxion Biotech AS',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00YTSS733',
CIK: '1828253',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2021-02-05',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'ADR',
IsDelisted: false,

Evaxion Biotech AS Fundamental Data is available in our Financial Data APIs

  • Net Revenue 124 K
  • EBITDA -19 789 500
  • Earnings Per Share -5.4
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Evaxion Biotech AS Earnings via APIs

  • Latest Release 2024-05-29
  • EPS/Forecast -0.55

Get Evaxion Biotech AS End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?